FDA Inspection 958738 — Michael Caswell, Ph.D.
The FDA completed an inspection of Michael Caswell, Ph.D. on Feb 4, 2016 in Fairfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 4, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Fairfield, NJ (United States)
Additional details
Clinical Investigator (CI)